CHMP Recommends Approval of Praluent® (alirocumab) Injection to Reduce Cardiovascular Risk in People with Established Atherosclerotic Cardiovascular Disease

TARRYTOWN, N.Y. and PARIS, Feb. 4, 2019 /PRNewswire/ — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for Praluent® (alirocumab) Injection, recommending a new indication to reduce cardiovascular risk by lowering low-density lipoprotein cholesterol (LDL-C) levels as an […]

Israeli Start-up Laminate, Developer of a Vascular Support Solution for Dialysis Patients, Has Completed a Capital Raising Round of $12 Million

TEL-AVIV, Israel, Jan. 31, 2019 /PRNewswire/ — The Israeli start-up Laminate Medical Technologies, developer of a vascular support device that is implanted in patients requiring dialysis, announces a capital raising round of $12 million. This round brings total investment in the company to date to $24 million. Participating in the current round is the leading dialyzer […]

Medtronic Valiant(TM) Captivia(TM) Demonstrates Durability, Safety, and Efficacy at Five Years in Transection Patients

DUBLIN and SAN DIEGO – January 30, 2019 – Medtronic plc (NYSE:MDT) today announced new data supporting the long-term durability, safety, and efficacy of the Valiant(TM) Captivia(TM) thoracic stent graft system for the treatment of blunt thoracic aortic injury (BTAI). The presentation by Himanshu J. Patel, M.D., University of Michigan Department […]

First-time Data Unveiled at the 31st Annual International Symposium on Endovascular Therapy

HOLLYWOOD, Fla., Jan. 29, 2019 /PRNewswire/ — The International Symposium on Endovascular Therapy (ISET), today announced that more than 20 highly anticipated research studies, including the first-time presentation of data from a promising clinical research trial, were presented during this year’s meeting, January 27-30 at The Diplomat Hotel in Hollywood, Florida. Below is a summary from […]

Eximo Medical Ltd. Announces First Commercial Case of Its B-Laser™ Atherectomy System in the U.S. and Publication of Its IDE and CE Studies Results

REHOVOT, Israel–(BUSINESS WIRE)–Eximo Medical Ltd., announced today the successful launch and first commercial use of the B-Laser™ Atherectomy System for treatment of peripheral vascular disease. Dr. Barry Weinstock of Orlando Heart & Vascular Institute, director of the catheterization laboratory at the Center for Cardiovascular Excellence in Orlando, Florida used the B-Laser™ Atherectomy System to successfully treat a patient […]

Avinger’s Pantheris SV (Small Vessel) Featured in Live Case Transmission at Leipzig Interventional Course (LINC) 2019

REDWOOD CITY, Calif., Jan. 28, 2019 (GLOBE NEWSWIRE) — Avinger, Inc. (Nasdaq: AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced that its Pantheris® SV (Small Vessel) image-guided atherectomy system was featured in a live case transmission at Leipzig Interventional Course (LINC) 2019, a leading […]

InspireMD Announces Presentation of Interim Data from Investigator-Initiated Study Comparing CGuard™ EPS with a Conventional Open-Cell Carotid Stent

TEL AVIV, Israel, Jan. 24, 2019 (GLOBE NEWSWIRE) — InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by the treatment of carotid artery disease, today announced the presentation of positive interim results from an investigator-initiated study of CGuard™ EPS. […]

GORE® TIGRIS® Vascular Stent Demonstrates High Patency Rates at 12 Months in Treating SFA and PPA Occlusive Lesions in Challenging Patients

FLAGSTAFF, Ariz.–(BUSINESS WIRE)–The GORE® TIGRIS® Vascular Stent, a flexible self-expanding stent to treat peripheral arterial disease (PAD) in the superficial femoral artery (SFA) and proximal popliteal artery (PPA) developed by W. L. Gore & Associates, Inc. (Gore), demonstrated that it is a safe and effective device that can be incorporated […]

InspireMD Announces Two Successful Live Clinical Case Transmissions Featuring CGuard™ EPS at the Leipzig Interventional Course (LINC) 2019

TEL AVIV, Israel, Jan. 23, 2019 (GLOBE NEWSWIRE) — InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by the treatment of carotid artery disease, today announced that two successful live cases featuring CGuard™ EPS were presented at LINC 2019, […]